Publicaciones (48) Publicaciones de JESÚS MIGUEL PRADILLO JUSTO

2024

  1. The role of gut microbiota in cerebrovascular disease and related dementia

    British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 816-839

2023

  1. Defective hippocampal neurogenesis underlies cognitive impairment by carotid stenosis-induced cerebral hypoperfusion in mice

    Frontiers in Cellular Neuroscience, Vol. 17

  2. Neutrophil β1 adrenoceptor blockade blunts stroke-associated neuroinflammation

    British Journal of Pharmacology, Vol. 180, Núm. 4, pp. 459-478

2022

  1. Del laboratorio a la clínica en el ictus isquémico agudo. Modelos experimentales in vitro e in vivo

    Revista de neurologia, Vol. 75, Núm. 9, pp. 283-293

2021

  1. Influence of metabolic syndrome on post-stroke outcome, angiogenesis and vascular function in old rats determined by dynamic contrast enhanced MRI

    Journal of Cerebral Blood Flow and Metabolism, Vol. 41, Núm. 7, pp. 1692-1706

2019

  1. Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance

    Stroke, Vol. 50, Núm. 11, pp. 3228-3237

  2. Toll-like receptor 4 regulates subventricular zone proliferation and neuroblast migration after experimental stroke

    Brain, Behavior, and Immunity, Vol. 80, pp. 573-582

2018

  1. Aspectos moleculares de la interacción de los fármacos con sus dianas farmacológicas

    Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 63-94

  2. Multi-modal imaging of long-term recovery post-stroke by positron emission tomography and matrix-assisted laser desorption/ionisation mass spectrometry

    Rapid Communications in Mass Spectrometry, Vol. 32, Núm. 9, pp. 721-729

  3. Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil–platelet interactions

    Journal of Cerebral Blood Flow and Metabolism, Vol. 38, Núm. 12, pp. 2150-2164

  4. TLR4-Binding DNA Aptamers Show a Protective Effect against Acute Stroke in Animal Models

    Molecular Therapy, Vol. 26, Núm. 8, pp. 2047-2059

2017

  1. Cannabinoid type-2 receptor drives neurogenesis and improves functional outcome after stroke

    Stroke, Vol. 48, Núm. 1, pp. 204-212

  2. Cytokines and Chemokines in Stroke

    Primer on Cerebrovascular Diseases: Second Edition (Elsevier Inc.), pp. 280-284

  3. Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemia

    Brain, Behavior, and Immunity, Vol. 61, pp. 117-126

  4. Specific Features of SVZ Neurogenesis after Cortical Ischemia: A Longitudinal Study

    Scientific Reports, Vol. 7, Núm. 1

  5. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation after Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke

    Stroke, Vol. 48, Núm. 6, pp. 1695-1699

2016

  1. A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke

    Journal of Cerebral Blood Flow and Metabolism, Vol. 36, Núm. 3, pp. 596-605

  2. Mechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR:LA-cp Corpulent Rat Strain

    Frontiers in Nutrition, Vol. 3

2015

  1. 18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, Núm. 3, pp. 503-511

  2. Aging increases microglial proliferation, delays cell migration, and decreases cortical neurogenesis after focal cerebral ischemia

    Journal of Neuroinflammation, Vol. 12, Núm. 1, pp. 1